Clinical Trial Update: Imaging Cannabinoid CB1 Receptors in Alcohol Dependence

View source ↗

Summary

This clinical trial update reports the completion of a study imaging cannabinoid CB1 receptors in individuals with alcohol use disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Alcoholism | Status: COMPLETED